What Patient Selection Criteria And Pre-Treatment Protocols Should Clinical Practitioners Follow For Non-Ablative Laser Photorejuvenation Procedures?

Non-ablative laser photorejuvenation is best suited to patients with mild-to-moderate photodamage, fine lines, early laxity, or enlarged pores—not severe wrinkles or major tissue laxity. Before treatment, practitioners should screen for contraindications, assess skin type and tanning history, select a wavelength and fluence appropriate to epidermal melanin, manage HSV risk, and establish rigorous eye, cooling, documentation, and patient-preparation protocols.

The central principle: select patients whose concerns match the achievable depth of non-ablative treatment, then reduce pigment and thermal risk through individualized settings, sun avoidance, appropriate prophylaxis, and controlled treatment preparation.

Select Patients Whose Concerns Match the Treatment

Appropriate clinical indications

Good candidates commonly have mild-to-moderate photodamage, fine rhytids, early loss of elasticity, enlarged pores, superficial dyspigmentation, telangiectasias, or atrophic scars.

The treatment is particularly appropriate for patients seeking gradual improvement with relatively limited recovery time.

When non-ablative treatment is unlikely to be sufficient

Patients with deep folds, severe rhytids, marked laxity, or advanced photoaging generally require a different strategy. Ablative resurfacing, radiofrequency tightening, or surgical procedures may provide more meaningful correction depending on the clinical problem.

Non-ablative treatment should not be presented as a method for completely eliminating deep wrinkles or substantial laxity.

Confirm realistic expectations

Patients should understand that results usually develop through cumulative dermal remodeling, rather than appearing after a single treatment. A planned series—often approximately 3 to 6 sessions at intervals of about 3 to 4 weeks, depending on the device and indication—may be required.

Explain that improvement is typically gradual and texture-focused, and discuss the possible need for maintenance treatments.

Screen for Contraindications and Risk Factors

Review medical and treatment history

Screen for:

Active infection or inflammation in the treatment area
A history of keloidal or hypertrophic scarring
Photosensitivity or photosensitizing medications
Oral isotretinoin use within the previous 6 months
Pregnancy or breastfeeding, where treatment should generally be deferred
Active connective tissue disease or other conditions that may impair healing
Recent or ongoing excessive sun exposure
A history of herpes labialis

The practitioner should also document previous cosmetic procedures and any history of abnormal pigmentation or delayed healing.

Manage herpes simplex risk

A history of recurrent herpes labialis is not necessarily an exclusion, but it requires a specific precaution. Prescribe prophylactic oral antiviral therapy according to applicable clinical guidance and the patient’s risk profile, beginning before treatment and continuing afterward as indicated.

This is particularly important when treating perioral or facial areas because thermal energy can reactivate HSV.

Evaluate sun exposure and tanning

Recent tanning increases epidermal melanin and therefore increases competition for absorbed light energy. Treatment should generally be postponed until the skin has returned to its baseline, untanned state.

Patients should receive clear instructions to avoid intentional sun exposure and use appropriate broad-spectrum photoprotection before and during the treatment course.

Match Skin Type and Device Parameters

Treat epidermal melanin as a competing chromophore

Melanin can absorb treatment energy intended to reach dermal targets. This creates a greater risk of epidermal overheating, burns, and post-inflammatory hyperpigmentation, particularly with shorter wavelengths or devices that deliver broad-spectrum light.

Skin typing and examination of the actual treatment area are therefore essential; Fitzpatrick type alone does not replace assessment of recent tanning.

Adjust wavelength and settings conservatively

Longer wavelengths are generally safer for patients with higher epidermal melanin because they are less strongly absorbed by melanin than shorter wavelengths. IPL and other lower-wavelength systems require particular caution on tanned or darker skin.

For Fitzpatrick types IV and V, and for recently exposed or naturally highly pigmented skin, consider conservative fluence, longer pulse durations where appropriate, adequate cooling, and close monitoring. Fitzpatrick type VI and patients with significant tanning may carry an unacceptable risk with some devices and should be managed only when the specific system, protocol, and practitioner expertise support treatment.

Perform a test area when risk is uncertain

A test spot can help evaluate the skin’s response when the patient has darker skin, recent tanning, a history of dyschromia, or other elevated risk factors. The device manufacturer’s parameters and the practitioner’s clinical protocol should determine the test-spot timing and interpretation.

Do not rely on a single universal fluence or pulse-duration protocol across different lasers, wavelengths, or skin types.

Complete the Pre-Treatment Preparation

Clean and prepare the treatment area

Remove all makeup, sunscreen, oils, and other surface products before delivering energy. Residual material can absorb light, increase localized heating, and interfere with consistent coupling between the handpiece and skin.

The treatment area and handpiece should be prepared according to standard infection-control and device-sanitization procedures.

Use topical anesthetic cautiously

If topical anesthetic is used, apply it only as permitted by the product labeling and the clinic’s protocol. Limit the treated surface area appropriately, remove the anesthetic completely before laser emission, and account for the risk of systemic lidocaine toxicity.

A commonly cited precaution is to restrict topical anesthetic application to approximately 300–400 cm², but the product, concentration, duration, patient factors, and local requirements must govern the final protocol.

Establish baseline documentation

Take standardized photographs before the first session. Use consistent lighting, camera distance, positioning, facial expression, and treatment angles so that subtle improvements across multiple sessions can be assessed objectively.

Photographs also help align the patient’s expectations with measurable clinical change.

Apply Essential Treatment-Day Safety Measures

Protect the eyes appropriately

Provide wavelength-appropriate ocular protection for the patient, practitioner, and all staff in the room. When treating near or within the orbital rim, use dedicated internal or external ocular shields as required by the device and treatment location.

The protection must be compatible with the emitted wavelength and used exactly as specified by the manufacturer and applicable safety standards.

Check cooling before delivering pulses

Test the device’s cooling system before firing treatment pulses. Adequate cooling helps protect the epidermis, particularly when treating patients with higher melanin levels or using parameters near the upper end of the protocol.

Cooling performance should be monitored throughout the procedure, not merely verified at the beginning.

Position and communicate with the patient

A supine position generally provides stable access to the face, neck, chest, or forearms and helps maintain consistent handpiece contact. Explain that visible flashes may be perceived around the eye protection so that the patient is not surprised during delivery.

Provide instructions about expected heat, discomfort, and the need to report excessive pain immediately.

Understanding the Trade-offs

Darker skin requires risk-based decision-making

Darker skin is not automatically unsuitable for every non-ablative device, but it has a narrower safety margin. The key risks are epidermal burns, prolonged erythema, and post-inflammatory hyperpigmentation.

Longer wavelengths, conservative parameters, test spots, effective cooling, and careful follow-up may reduce risk; they do not eliminate it.

More energy does not guarantee better results

Increasing fluence or pulse density can increase thermal injury without producing proportionally better rejuvenation. Treatment should prioritize controlled, reproducible dermal heating rather than maximal energy delivery.

Device-specific protocols and clinical endpoints should guide escalation.

Non-ablative does not mean risk-free

Although the epidermis is not intentionally removed as it is with ablative resurfacing, non-ablative devices can still cause burns, pigmentary change, HSV reactivation, scarring, and ocular injury if used improperly.

Patients should receive clear information about these risks and about the possibility that treatment may be deferred when the skin is tanned, infected, or otherwise unsuitable.

How to Apply This to Clinical Practice

Use the following framework before scheduling or beginning treatment:

If your primary focus is patient selection: Choose patients with mild-to-moderate photodamage, fine rhytids, early laxity, or superficial pigmentary and vascular concerns, while referring severe laxity and deep rhytids for more intensive or alternative treatment.
If your primary focus is pigment safety: Assess Fitzpatrick type and current tanning, prefer appropriately selected longer wavelengths for darker skin, and use conservative settings, test spots, and close monitoring when indicated.
If your primary focus is medical risk reduction: Screen for infection, keloid tendency, photosensitivity, recent isotretinoin, pregnancy or breastfeeding, connective tissue disease, and HSV history before treatment.
If your primary focus is procedural safety: Remove all topical products, verify cooling, use wavelength-specific ocular protection, sanitize the handpiece, and document standardized baseline photographs.
If your primary focus is patient satisfaction: Explain that improvement is gradual, typically requires multiple sessions, and will not fully correct deep wrinkles or major laxity.

A disciplined selection and preparation process is the foundation for achieving meaningful rejuvenation while keeping non-ablative laser risk within an acceptable clinical margin.

Summary Table:

Criteria/Protocol	Key Points
Patient Selection	Mild-to-moderate photodamage, fine lines, early laxity, enlarged pores; not for severe wrinkles or laxity
Contraindications	Active infection, keloid history, photosensitivity, recent isotretinoin (within 6 months), pregnancy, etc.
HSV Risk	Prophylactic antivirals for history of herpes labialis
Skin Type Assessment	Fitzpatrick type and tanning status; longer wavelengths for darker skin
Pre-Treatment Prep	Clean skin, remove makeup, cautious topical anesthetic, baseline photos
Safety Measures	Eye protection, cooling check, test spot if uncertain
Expectations	Gradual results over 3-6 sessions; not for deep wrinkles or major laxity

Ready to enhance your practice with advanced non-ablative laser technology? At BELIS, we specialize in professional-grade medical aesthetic equipment for clinics and premium salons, including a full range of laser systems (Diode, Alexandrite, CO2, Erbium, Nd:YAG, Pico), IPL, and PDT devices. Our solutions are designed to help you achieve optimal patient outcomes with safety and efficacy. Contact us today to explore our portfolio and see how we can support your clinical success.